Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agentsAbdelsattar M. Omar, Martin K. Safo, Qiongxia Chen et al.|MedChemComm|2019Cited by 9
Hemoglobin: A Target for Sickle Cell Disease Drug DiscoveryAkua K. Donkor, Martin K. Safo, Albert Opare et al.|Unknown|2026Cited by 0